抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產品編號 | 圖片 | 產品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
Efaproxiral sodium，98% | C20H22NNaO4 | |||
|
|
|||||
|
Valganciclovir hydrochloride，98% | C14H23ClN6O5 | |||
|
|
|||||
|
BEC hydrochloride，98% | C5H13BClNO4S | |||
|
|
|||||
|
Molsidomine，98% | C9H14N4O4 | |||
|
|
|||||
|
CH 223191，99% | C19H19N5O | |||
|
|
|||||
|
Moroxydine Hydrochloride，99% | C6H14ClN5O | |||
|
|
|||||
|
MI 2 (MALT1 inhibitor)，99% | C19H17Cl3N4O3 | |||
|
|
|||||
|
(D-ALA1)-PEPTIDE T AMIDE，98% | C35H56N10O15 | |||
|
|
|||||
|
YYA-021，98% | C18H27N3O2 | |||
|
|
|||||
|
1400 W Dihydrochloride，98% | C10H17Cl2N3 | |||
|
|
|||||
|
Y-320，98% | C27H29ClN6O2 | |||
|
|
|||||
|
BMS-378806，98% | C22H22N4O4 | |||
|
|
|||||
|
Maraviroc，99% | C29H41F2N5O | |||
|
|
|||||
|
INF39，99% | C12H13ClO2 | |||
|
|
|||||
|
Suplatast Tosilate，98% | C23H33NO7S2 | |||
|
|
|||||
|
INCB8761(PF-4136309)，99% | C29H31F3N6O3 | |||
|
|
|||||
|
BX471，95% | C21H24ClFN4O3 | |||
|
|
|||||
![N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide](images/ce/HY-77048.gif)
|
N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide，98% | C14H10N4O3 | |||
|
|
|||||
|
Etofenamate，98% | C18H18F3NO4 | |||
|
|
|||||
|
AZD2098，99% | C11H9Cl2N3O3S | |||
|
|
|||||
|
MK-0812，98% | C24H34F3N3O3 | |||
|
|
|||||
|
Vitamin B2 Tetrabutyrate，≥98%(HPLC) | C33H44N4O10 | |||
|
|
|||||
|
ITMN 4077，98% | C26H40N4O8S | |||
|
|
|||||
|
TFAP，99% | C13H10F3N3O | |||
|
|
|||||
|
GLX351322，98% | C21H25N3O5S | |||
|
|
|||||
|
FK 3311，98% | C15H13F2NO4S | |||
|
|
|||||
